SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-161641
Filing Date
2023-06-06
Accepted
2023-06-06 16:22:00
Documents
12
Period of Report
2023-06-01
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d461566d8k.htm   iXBRL 8-K 37774
  Complete submission text file 0001193125-23-161641.txt   160013

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cbay-20230601.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20230601_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20230601_pre.xml EX-101.PRE 11261
6 EXTRACTED XBRL INSTANCE DOCUMENT d461566d8k_htm.xml XML 3353
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36500 | Film No.: 23996372
SIC: 2834 Pharmaceutical Preparations